Page last updated: 2024-08-21

d-alpha tocopherol and flunarizine

d-alpha tocopherol has been researched along with flunarizine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Annoura, H; Imajo, S; Miyajima, A; Nakanishi, K; Takemoto, N; Tamura, S; Tamura-Horikawa, Y; Toba, T	1
Inazu, M; Kawakatsu, N; Kimura, M; Kishii, K; Kubota, N; Masuda, T; Mitani, M; Namiki, T; Yamada, K	1
Dai, Q; Duan, M; Hellström, S; Ku, W; Niu, K; Tong, B; Xie, W	1

Trials

1 trial(s) available for d-alpha tocopherol and flunarizine

Article	Year
Comparison of Therapeutic Results with/without Additional Hyperbaric Oxygen Therapy in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Prospective Study. Audiology & neuro-otology, 2021, Volume: 26, Issue:1 Topics: Adult; Aged; Audiometry, Pure-Tone; Combined Modality Therapy; Drugs, Chinese Herbal; Evoked Potentials, Auditory, Brain Stem; Female; Flunarizine; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Nerve Growth Factor; Prednisone; Prospective Studies; Thiamine; Treatment Outcome; Vasodilator Agents; Vitamin A; Vitamin B 12; Vitamin E; Vitamins; Young Adult	2021

Article

Year

Comparison of Therapeutic Results with/without Additional Hyperbaric Oxygen Therapy in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Prospective Study.

Audiology & neuro-otology, 2021, Volume: 26, Issue:1

Topics: Adult; Aged; Audiometry, Pure-Tone; Combined Modality Therapy; Drugs, Chinese Herbal; Evoked Potentials, Auditory, Brain Stem; Female; Flunarizine; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Nerve Growth Factor; Prednisone; Prospective Studies; Thiamine; Treatment Outcome; Vasodilator Agents; Vitamin A; Vitamin B 12; Vitamin E; Vitamins; Young Adult

2021

Other Studies

2 other study(ies) available for d-alpha tocopherol and flunarizine

Article	Year
Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity. Journal of medicinal chemistry, 2000, Sep-07, Volume: 43, Issue:18 Topics: Acoustic Stimulation; Aniline Compounds; Animals; Anticonvulsants; Antioxidants; Calcium Channel Blockers; Cerebral Cortex; In Vitro Techniques; Lipid Peroxidation; Mice; Mice, Inbred DBA; Models, Molecular; Molecular Conformation; Neuroprotective Agents; Piperazines; Rats; Seizures; Sodium Channel Blockers	2000
Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities. Bioorganic & medicinal chemistry letters, 2002, Aug-05, Volume: 12, Issue:15 Topics: Animals; Antioxidants; Arteries; Calcium; Calcium Channel Blockers; Dogs; In Vitro Techniques; Inhibitory Concentration 50; Muscle Contraction; Muscle, Smooth, Vascular; Piperazines; Rats; Structure-Activity Relationship; Vasodilation	2002

Article

Year

Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity.

Journal of medicinal chemistry, 2000, Sep-07, Volume: 43, Issue:18

Topics: Acoustic Stimulation; Aniline Compounds; Animals; Anticonvulsants; Antioxidants; Calcium Channel Blockers; Cerebral Cortex; In Vitro Techniques; Lipid Peroxidation; Mice; Mice, Inbred DBA; Models, Molecular; Molecular Conformation; Neuroprotective Agents; Piperazines; Rats; Seizures; Sodium Channel Blockers

2000

Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities.

Bioorganic & medicinal chemistry letters, 2002, Aug-05, Volume: 12, Issue:15

Topics: Animals; Antioxidants; Arteries; Calcium; Calcium Channel Blockers; Dogs; In Vitro Techniques; Inhibitory Concentration 50; Muscle Contraction; Muscle, Smooth, Vascular; Piperazines; Rats; Structure-Activity Relationship; Vasodilation

2002